Unlock instant, AI-driven research and patent intelligence for your innovation.

Analog of actinomycin D

A technology of actinomycin and analogs, applied in the field of new compounds, can solve problems such as high toxicity, and achieve the effect of reducing toxicity and improving anti-tumor activity

Inactive Publication Date: 2009-05-06
LANZHOU UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the analogues obtained through these technical measures, some show better biological activity, and occasionally some toxicity is reduced, but as a drug, the toxicity of the obtained product is still relatively high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Analog of actinomycin D
  • Analog of actinomycin D
  • Analog of actinomycin D

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1: [D-Phe 2 , D-MeVal 5 ] 2 Synthesis of AMD

[0023]I Dissolve 0.63 g (2.26 mmol) of the compound N-benzyloxycarbonyl-N-methylglycine tert-butyl ester in 6 ml of anhydrous methanol (MeOH), add 80 mg of 10% Pd / C, stir for 2 hours after hydrogenation, filter and concentrate , add Z-Pro 0.535g (2.15mmol) to the residue, dissolve with dry dichloromethane (DCM) and cool to -10°C, add 0.44g (2.15mmol) of DCC in dichloromethane solution, at -10°C After reacting for 2 hours, react overnight at room temperature. The DCU generated by the reaction was filtered off, the filtrate was concentrated, and the residue was dissolved in ethyl acetate (EtOAc), followed by 10% citric acid aqueous solution, 10% sodium bicarbonate (NaHCO 3 ) aqueous solution, washed with saturated sodium chloride (NaCl) aqueous solution, and washed with anhydrous sodium sulfate (NaCl) 2 SO 4 )dry. After filtration, the solvent was evaporated under reduced pressure, and the crude product was sub...

Embodiment 2

[0030] Embodiment 2: [D-Phe 2 , D-MePhe 5 ] 2 Synthesis of AMD

[0031] Reaction steps I to III and synthetic process are identical with embodiment 1 in the present embodiment;

[0032] IV Take the compound N-benzyloxycarbonyl-threonyl-D-phenylalanyl-prolyl-N-methylglycine tert-butyl ester 423mg (0.68mmol) and Boc-D-Me Val 264.8mmg (0.95mmol), Dissolve in dry DCM and cool to -10°C, add 195.5 mg (0.95 mmol) of DCC in DCM, and 82.7 mg (0.68 mmol) of DMAP, react overnight at room temperature, filter out the DCU generated by the reaction, concentrate the filtrate, and dissolve the residue in EtOAc, sequentially with 10% aqueous citric acid, 10% NaHCO 3 solution, washed with saturated NaCl, and washed with anhydrous NaCl 2 SO 4 dry. Filtration, the solvent was evaporated under reduced pressure, and the crude product was subjected to silica gel column chromatography (EtOAc:PE 2:1) to obtain white powder N-tert-butoxycarbonyl-D-N-methylphenylalanyl-N-benzyloxycarbonyl-threonin...

Embodiment 3

[0036] Example 3: [D-MeVal 2 ] 2 Synthesis of AMD

[0037] Reaction steps 1 and synthetic process are identical with embodiment 1 in the present embodiment;

[0038] II Dissolve 1.90 g (5.05 mmol) of the compound N-benzyloxycarbonyl-prolyl-N-methylglycine tert-butyl ester in 25 ml of anhydrous MeOH, add 212 mg of 10% Pd / C, hydrogenate for 2 hours, filter, concentrate, Add 1.47g (5.56mmol) of Z-D-MeVal to the residue, dissolve in dry DCM and cool to -10°C, add 1.15g (5.56mmol) of DCC in DCM, react at -10°C for 2 hours, then react overnight at room temperature, The DCU generated by the reaction was filtered off, the filtrate was concentrated, and the residue was dissolved in EtOAc, followed by 10% citric acid aqueous solution, 10% NaHCO 3 solution, washed with saturated NaCl, and washed with anhydrous NaCl 2 SO 4 dry. Filtration, the solvent was evaporated under reduced pressure, and the crude product was subjected to silica gel column chromatography (EtOAc:PE 2:1) to obta...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
control rateaaaaaaaaaa
Login to View More

Abstract

The invention relates to a kind of new compound, in particular, it is an analogue of antinomycin D and preparation method of said compound. Said invention also provides the structural formula of said compound.

Description

technical field [0001] The present invention relates to a class of novel compounds, specifically a class of analogs of actinomycin D, and a preparation method of such compounds. Background technique [0002] Actinomycin D (Actinomycin D, AMD, also known as dactinomycin), is one of the national basic medical insurance drug varieties, and is widely used in clinical treatment of various malignant tumors, such as Wilm's Tumor, Wilm's Tumor, Choriocarcinoma of pregnancy, malignant hydatidiform mole, Hodgkin's malignant lymphoma (Hodgkin's disease) and other malignant tumors, have significant curative effect. In recent years, it has been found that actinomycin D has the effect of anti-HIV virus, and has the effect of inducing apoptosis on Kaposi's tumor cells which are susceptible to infection in AIDS patients. [0003] The structure of actinomycin D is shown in the following formula. The molecule contains two cyclic pentapeptides and a planar phenoxazinone, wherein the 2 amino a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/64
Inventor 王锐张邦治倪京满
Owner LANZHOU UNIVERSITY